Factors Associated With Success of NIPPV in ALS Patients
1 other identifier
observational
51
1 country
1
Brief Summary
This is a retrospective cohort study to assess the factor associated with success of non-invasive positive ventilation in ALS patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 4, 2022
CompletedFirst Posted
Study publicly available on registry
October 17, 2022
CompletedStudy Start
First participant enrolled
October 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 27, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 4, 2023
CompletedJuly 16, 2024
July 1, 2024
9 days
October 4, 2022
July 13, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Success of NIPPV
The success of NIPPV application was defined empirically as use of ≥ 2 hours per day and the failure as use of \< 2 hours for a day or conversion to invasive positive pressure ventilation via tracheostomy or refuse to apply NIPPV during hospitalization.
through intervention completion, with an average of 10 days
Secondary Outcomes (1)
Lenght of stay
through intervention completion, with an average of 10 days
Eligibility Criteria
ALS patients who were admitted for applying non-invasive positive pressure ventilation initially.
You may qualify if:
- Patients fulfilling the El Escorial World Federation criteria for probable, or definite ALS
- Aged ≥ 19 years
- Patients who performed blood gas analysis including venous blood gas and arterial blood gas before NIPPV application.
You may not qualify if:
- Patients who had experience in applying the NIPPV or currently using NIPPV
- Patients who applied in outpatient settings
- Patients who did not perform blood gas analysis before NIPPV application
- Patietns who had a history of asthma or COPD,
- Patients who didn't have any record of NIPPV application time
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Seoul National University Bundang Hospital
Seongnam-si, 13620, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jaewon Beom, PhD
Department of Rehabilitation Medicine, Seoul National University Bundang Hospital
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Associate Professor
Study Record Dates
First Submitted
October 4, 2022
First Posted
October 17, 2022
Study Start
October 18, 2022
Primary Completion
October 27, 2022
Study Completion
October 4, 2023
Last Updated
July 16, 2024
Record last verified: 2024-07